Munich-based HealthTech startup Ortivity secured €200 million in a strategic funding round. Existing majority investor Apheon led the transaction. Swiss private equity firm Unigestion also provided new backing. This capital injection aims to reshape German orthopaedic care.
The funding will accelerate Ortivity's network expansion across Germany. It also supports the further development of its integrated, physician-led care model. Ortivity, founded in 2022, currently operates over 100 locations. These are grouped into three regional clusters.
Expanding Integrated Orthopaedic Services
Unigestion now holds a significant minority stake in Ortivity. Apheon remains the lead investor. The deal facilitated a partial exit for existing shareholders. This strategic move strengthens Ortivity's capital base.
Dr. med. Michael Thorwarth joined Ortivity as co-CEO, coinciding with this funding. Ortivity delivers integrated orthopaedic services. These span diagnostics, anaesthesia, surgery, and aftercare. The company aims to set new standards in treatment quality.
The HealthTech sector in Germany continues to attract substantial private equity investment. Companies like Doctolib and Ada Health also innovate within the broader digital health landscape. Ortivity's expansion further solidifies its position among HealthTech startups focused on specialized care.
Regulatory approvals are pending for the transaction.
